Ceyhan Mehmet, Ozsurekci Yasemin, Gürler Nezahat, Karadag Oncel Eda, Camcioglu Yıldız, Salman Nuran, Celik Melda, Emiroglu Melike Keser, Akin Fatih, Tezer Hasan, Parlakay Aslinur Ozkaya, Tuygun Nilden, Tamburaci Diyar, Dinleyici Ener Cagri, Karbuz Adem, Uluca Ünal, Alhan Emre, Çay Ümmühan, Kurugol Zafer, Hatipoğlu Nevin, Şiraneci Rengin, İnce Tolga, Sensoy Gülnar, Belet Nursen, Coskun Enes, Yilmaz Fatih, Hacimustafaoglu Mustafa, Celebi Solmaz, Celik Ümit, Ozen Metehan, Akaslan Aybüke, Devrim İlker, Kuyucu Necdet, Öz Fatmanur, Bozdemir Sefika Elmas, Kara Ahu
a Department of Pediatric Infectious Diseases , Hacettepe University Faculty of Medicine , Ankara , Turkey.
b Department of Microbiology and Clinical Microbiology , Istanbul University Faculty of Medicine , Istanbul , Turkey.
Hum Vaccin Immunother. 2016 Nov;12(11):2940-2945. doi: 10.1080/21645515.2016.1209278. Epub 2016 Jul 25.
This is an observational epidemiological study to describe causes of bacterial meningitis among persons between 1 month and 18 y of age who are hospitalized with suspected bacterial meningitis in 7 Turkish regions. covering 32% of the entire population of Turkey. We present here the results from 2013 and 2014. A clinical case with meningitis was defined according to followings: any sign of meningitis including fever, vomiting, headache, and meningeal irritation in children above one year of age and fever without any documented source, impaired consciousness, prostration and seizures in those < 1 y of age. Single tube multiplex PCR assay was performed for the simultaneous identification of bacterial agents. The specific gene targets were ctrA, bex, and ply for N. meningitidis, Hib, and S. pneumoniae, respectively. PCR positive samples were recorded as laboratory-confirmed acute bacterial meningitis. A total of 665 children were hospitalized for suspected acute meningitis. The annual incidences of acute laboratory-confirmed bacterial meningitis were 0.3 cases / 100,000 population in 2013 and 0.9 cases/100,000 in 2014. Of the 94 diagnosed cases of bacterial meningitis by PCR, 85 (90.4%) were meningococcal and 9 (9.6%) were pneumococcal. Hib was not detected in any of the patients. Among meningococcal meningitis, cases of serogroup Y, A, B and W-135 were 2.4% (n = 2), 3.5% (n = 3), 32.9% (n = 28), and 42.4% (n = 36). No serogroup C was detected among meningococcal cases. Successful vaccination policies for protection from bacterial meningitis are dependent on accurate determination of the etiology of bacterial meningitis. Additionally, the epidemiology of meningococcal disease is dynamic and close monitoring of serogroup distribution is comprehensively needed to assess the benefit of adding meningococcal vaccines to the routine immunization program.
这是一项观察性流行病学研究,旨在描述土耳其7个地区1个月至18岁因疑似细菌性脑膜炎住院的人群中细菌性脑膜炎的病因,这些地区覆盖了土耳其32%的总人口。我们在此展示2013年和2014年的研究结果。脑膜炎临床病例根据以下标准定义:1岁以上儿童出现任何脑膜炎体征,包括发热、呕吐、头痛和脑膜刺激征,1岁以下儿童出现无明确病因的发热、意识障碍、虚脱和惊厥。采用单管多重PCR检测法同时鉴定细菌病原体。特定基因靶点分别为脑膜炎奈瑟菌的ctrA、bex和肺炎链球菌的ply,bex用于鉴定b型流感嗜血杆菌。PCR阳性样本被记录为实验室确诊的急性细菌性脑膜炎。共有665名儿童因疑似急性脑膜炎住院。2013年急性实验室确诊细菌性脑膜炎的年发病率为0.3例/10万人口,2014年为0.9例/10万人口。在94例经PCR诊断为细菌性脑膜炎的病例中,85例(90.4%)为脑膜炎球菌性,9例(9.6%)为肺炎球菌性。所有患者均未检测到b型流感嗜血杆菌。在脑膜炎球菌性脑膜炎中,Y、A、B和W - 135血清群病例分别占2.4%(n = 2)、3.5%(n = 3)、32.9%(n = 28)和42.4%(n = 36)。脑膜炎球菌病例中未检测到C血清群。预防细菌性脑膜炎的成功疫苗接种策略取决于对细菌性脑膜炎病因的准确判定。此外,脑膜炎球菌病的流行病学是动态变化的,全面密切监测血清群分布对于评估将脑膜炎球菌疫苗添加到常规免疫规划中的益处十分必要。